Möchten Sie immer auf dem neuesten Stand bleiben?

Immediate Release – July 23rd, 2021 Louvain-la-Neuve, Belgium, July 23rd, 2021 - In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and...

Publication immédiate – 23 juillet 2021 Louvain-la-Neuve, Belgique, 23 juillet 2021 - Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et...

Gereglementeerde informatie Nyrstar NV publiceert de oproeping voor de buitengewone algemene aandeelhoudersvergadering van 23 augustus 2021 23 juli 2021 om 07u00 CEST Nyrstar NV (de...

Regulated Information Nyrstar NV releases notice for the extraordinary general shareholders’ meeting to be held on 23 August 2021 23 July 2021 at 07.00 CEST Nyrstar NV (the “Company”)...

PUBLICATION D’UNE NOTIFICATION DE TRANSPARENCE CONFORMÉMENT À LA LOI DU 02/05/2007 SUR LA PUBLICATION DE PARTICIPATIONS IMPORTANTES Une notification du 20 juillet 2021 émise par Ackermans &van...

OPENBAARMAKING VAN EEN TRANSPARANTIEKENNISGEVING OVEREENKOMSTIG DE WET VAN 02/05/2007 OP DE OPENBAARMAKING VAN BELANGRIJKE DEELNEMINGEN Uit een kennisgeving van 20 juli 2021 verricht door Ackermans...

PUBLICATION OF A TRANSPARENCY NOTIFICATION IN ACCORDANCE WITH THE LAW OF 02/05/2007 ON THE DISCLOSURE OF IMPORTANT PARTICIPATIONS A notification of 20 July 2021 issued by Ackermans & van Haaren...

July 22, 2021Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and...

Phase 1 IMMUNICY-1 trial evaluating CYAD-211 in relapsed/refractory multiple myeloma (r/r MM) showed dose dependent engraftment up to dose level three (300×106 cells per infusion) with no...

Article 8:6 of the Royal Decree of 29 April 2019, which implements the new Belgian Code of Companies and Associations as of 01/01/2020, stipulates that any disposal of own shares has to be made...